Phase 3 Results Offer Hope for Patients With Myelodysplastic Syndromes
Senior author of the study and Yale Cancer Center expert Amer Zeidan , MBBS, says the results showed that imetelstat, a first-in-class telomerase inhibitor, leads to durable red blood cell transfusion independence and a significant improvement in anemia in heavily transfused lower-risk MDS patients.
Neural Patterns Differentiate Traumatic From Sad Autobiographical Memories in PTSD
Investigators from Yale and Mount Sinai schools of medicine studied the neural activity of 28 people diagnosed with post-traumatic stress disorder (PTSD). They found that autobiographical memories for sad and neutral memories are processed differently in the brain than for traumatic memories. The findings were published in Nature Neuroscience. The co-senior author is Ilan Harpaz-Rotem, PhD, professor of psychiatry and of psychology at Yale School of Medicine.
First White House Initiative on Women’s Health Research to Be Directed by Yale’s Carolyn M. Mazure
President Biden has announced the launch of the new White House Initiative on Women’s Health Research, to be led by first lady Jill Biden and directed by Carolyn M. Mazure, PhD, founder and director of Yale School of Medicine’s Women’s Health Research at Yale.
Brain Fog: New Study Examines Causes of This Long COVID Symptom
A new study finds that neuroinflammation and blood-brain-barrier dysfunction are not likely drivers of the neuropsychiatric symptoms of Long COVID, giving researchers more clues in their quest to uncover what actually may be the culprit. This study is the first time researchers have tested a large cohort of people living with Long COVID for spinal fluid markers of brain inflammation and blood-brain-barrier dysfunction.
Parkinson’s Disease Research Center Being Formed at Yale
Yale School of Medicine has announced the formation of the Stephen and Denise Adams Center for Parkinson’s Disease Research, whose goal is to change the ways that Parkinson’s is diagnosed and treated. The director of the center will be Clemens Scherzer, MD, who comes to Yale in January 2024 from Harvard Medical School.
Yale Joins Chan Zuckerberg Initiative Biohub NY
Yale University is one of three partners that will form a new biomedical research hub announced by the Chan Zuckerberg Initiative (CZI). The mission of CZ Biohub New York, to be located in New York City, will be to bioengineer immune cells to detect the earliest stages of diseases—potentially allowing clinicians to intervene before they become symptomatic and detectable using current approaches. John Tsang, PhD, will lead Yale's team.
Brain Control in Infancy Linked to Cognitive Ability in Toddlers
The findings give new insight into how the brain functions very early in life and could point to treatment options for correcting developmental trajectories affected by neurodevelopmental disorders, the researchers said.Source: YaleNews
CDC Director Talks About Building Trust, Addressing Health Disparities During Yale Visit
Mandy Cohen, MD ’05, MPH, director of the U.S. Centers for Disease Control and Prevention, joined Yale School of Public Health Dean Megan L. Ranney, MD, for a ‘fireside chat’ about health care leadership and the future of public health on Oct. 5 in Harkness Auditorium.
Future Data Scientists and Biomedical Informatics Researchers Will Be Trained in Master’s Program at Yale
Yale School of Medicine’s master’s degree program in Computational Biology and Bioinformatics (CBB), with a new biomedical informatics & data science concentration, seeks to train graduates in biomedical sciences, engineering, and computer science.
Teenage Brain Development Study Forecasts Drinking Behavior by Sex
Researchers sorted through a massive MRI dataset of teenage brains to see if they could predict drinking behavior in adolescents by looking at how two systems rewire during development. The study revealed that the way inhibitory and reward pathways develop can help forecast how likely those teens are to drink heavily in the years to come.